Patrick D. Spangler - 28 Aug 2025 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Reporting relationship: Director
Issuer ticker: OPRX
Reported as of: 28 Aug 2025
Net transaction value: -$194,489
SEC form: 4
Accepted by SEC: 11 Sep 2025, 13:55:07 UTC
Prior SEC filing: 12 Jun 2025
Next SEC filing: 10 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Marion Odence-Ford, by Power of Attorney

Key filing fact

Patrick D. Spangler filed Form 4 for OptimizeRx Corp (OPRX) on 11 Sep 2025.

Key facts

This page summarizes Patrick D. Spangler's Form 4 filing for OptimizeRx Corp (OPRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Sep 2025, 13:55.

Change

Previous filing in this sequence was filed on 12 Jun 2025.
Current net transaction value: -$194,489.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001296525 Primary reporting owner

Spangler Patrick D

Relationship: Director
Address: C/O OPTIMIZERX CORPORATION, 260 CHARLES STREET, SUITE 302, WALTHAM
Signature: /s/ Marion Odence-Ford, by Power of Attorney
Signature date: 11 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OPRX transaction

Common Stock

Sale

Transaction value: $194,489
Shares: -11,120
Change %: -20%
Price: $17.49
Shares after: 44,215
Date: 28 Aug 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.47 through $18.43. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, complete information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC remarks

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.